Nippon Express has received IATA CEIV Pharma certification for its Narita Temperature-Controlled Hub (NTCH), for quality transport operations between the hub and Narita Airport, effective March 15.
This is the second pharmaceutical-related quality certification awarded to NTCH, the first being the Good Distribution Practice (GDP) certification it received in March 2020.
In October 2019, Nippon Express began seeking International Air Transport Association (IATA) Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification as a member of the community, hosted by Narita International Airport Corporation (NIAC). Finally, with NIAC’s assistance, the company obtained certification as a forwarder in this community.
NTCH is an important node connecting Japan with the rest of the world, and this certification incorporating GDP standards from countries around the world will enable it to provide more secure and better-quality end-to-end pharmaceutical transport services.
The ‘Nippon Express Group Business Plan 2023 — Dynamic Growth’ regards the pharmaceutical industry as a priority industry, and this fiscal year Nippon Express completed construction of four GDP-compliant dedicated pharmaceutical warehouses in Japan (East Japan, West Japan, Kyushu and Toyama) that have begun providing services to customers.
The company is also engaged overseas in obtaining GDP certification and otherwise reinforcing its business infrastructure.
